June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

Zhejiang University School of Medicine in China, along with American researchers, has found no link between late-life intake ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

A breakthrough clinical trial in Japan reveals that a vitamin B3 derivative significantly improves symptoms of the rare ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and ...

Diabetes is increasing due to obesity and lack of exercise, and if type 2 diabetes patients are accompanied by mental illness ...

Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...

Dr. Beddingfield is expected to contribute to Neurodon’s Board in several key areas as the company transitions its pipeline to clinical development. His extensive experience developing successful ...

Pathophysiology of type 2 diabetes. This condition is caused by a relative deficiency of insulin and not an absolute deficiency. This means that the body is unable to produce adequate insulin to ...